moxifloxacine fresenius kabi 400 mg/250 ml infusionslösung
fresenius kabi - moxifloxacin-hydrochlorid - infusionslösung - 400 mg/250 ml - moxifloxacin-hydrochlorid 437.5 mg - moxifloxacin
moxifloxacine fresenius kabi 400 mg/250 ml infusionslösung
fresenius kabi - moxifloxacin-hydrochlorid - infusionslösung - 400 mg/250 ml - moxifloxacin-hydrochlorid 437.5 mg - moxifloxacin
moxifloxacin kabi 400 mg infusionslösung
fresenius kabi deutschland gmbh (3003660) - moxifloxacinhydrochlorid (ph.eur.) ((mit angaben zum wassergehalt)) - infusionslösung - teil 1 - infusionslösung; moxifloxacinhydrochlorid (ph.eur.) ((mit angaben zum wassergehalt)) (29248) 437,5 milligramm
abirateron fresenius kabi 500 mg filmtablette
fresenius kabi - abiraterone acetat - filmtablette - 500 mg - abiraterone acetat 500 mg - abiraterone
moxifloxacin kabi 400 mg infusionslösung
fresenius kabi austria gmbh - moxifloxacin hydrochlorid -
abirateron fresenius kabi 500 mg film-coat. tabl.
abirateron fresenius kabi 500 mg compr. pellic.
abirateron fresenius kabi 500 mg filmomh. tabl.
moxifloxacine teva 400 mg filmtablette
teva pharma belgium - moxifloxacin - filmtablette - 400 mg - moxifloxacin 400 mg - moxifloxacin
moxifloxacine rivopharm filmtabletten
rivopharm sa - moxifloxacinum - filmtabletten - moxifloxacinum 400 mg ut moxifloxacini hydrochloridum, cellulosum microcristallinum, carmellosum natricum conexum, povidonum k 30, magnesii stearas, coperta: macrogolum 3350, talcum, poly(alcohol vinylicus), e 110 160 µg, e 171, e 172 (rubrum), pro compresso obducto corresp. natrium max. 3.78 mg. - infektionskrankheiten - synthetika